Compare · ICL vs SNES
ICL vs SNES
Side-by-side comparison of ICL Group Ltd. (ICL) and SenesTech Inc. (SNES): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ICL and SNES operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- ICL is the larger of the two at $7.28B, about 1127.9x SNES ($6.5M).
- SNES has been more active in the news (9 items in the past 4 weeks vs 7 for ICL).
- ICL has more recent analyst coverage (7 ratings vs 0 for SNES).
- Company
- ICL Group Ltd.
- SenesTech Inc.
- Price
- -
- -
- Market cap
- $7.28B
- $6.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2014
- 2016
- News (4w)
- 7
- 9
- Recent ratings
- 7
- 0
ICL Group Ltd.
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment extracts potash from the Dead Sea; mines and produces potash and salt; produces Polysulphate; produces, markets, and sells magnesium and magnesium alloys, as well as related by-products, including chlorine and sylvinite; and sells salt. The Phosphate Solutions segment uses phosphate commodity products to produce specialty products; produces and markets phosphate-based fertilizers, as well as sulphuric acid, green phosphoric acid, and phosphate fertilizers; and manufactures thermal phosphoric acid for various industrial end markets, such as oral care, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. It also develops and produces functional food ingredients and phosphate additives for use in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets; and produces milk and whey proteins for the food ingredients industry. The IAS segment develops, manufactures, markets, and sells fertilizers based primarily on nitrogen, potash, and phosphate, including water soluble specialty, liquid, soluble, and controlled-release fertilizers. It sells its products through marketing companies, agents, and distributors. The company was formerly known as Israel Chemicals Ltd. and changed its name to ICL Group Ltd in May 2020. ICL Group Ltd was founded in 1968 and is headquartered in Tel Aviv, Israel.
SenesTech Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Latest ICL
- SEC Form 4 filed by EVP, Global CIO Kilstein Alegra
- SEC Form 4 filed by ICL CFO Alperovitz Asaf
- SEC Form 6-K filed by ICL Group Ltd.
- SEC Form 6-K filed by ICL Group Ltd.
- SEC Form 6-K filed by ICL Group Ltd.
- SEC Form 6-K filed by ICL Group Ltd.
- ICL Reports Second Quarter 2026 Results
- SEC Form 6-K filed by ICL Group Ltd.
- ICL Announces Second Quarter 2026 Earnings Call
- SEC Form 6-K filed by ICL Group Ltd.
Latest SNES
- SEC Form S-8 filed by SenesTech Inc.
- Chief Executive Officer Edell Michael bought $1,210 worth of shares (1,000 units at $1.21), increasing direct ownership by 20% to 6,000 units (SEC Form 4)
- SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
- Large owner Glenbrook Capital Management bought $27,865 worth of shares (21,490 units at $1.30) (SEC Form 4)
- SenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates
- SenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent Infestations
- SenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum
- SenesTech to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026